Latest Strategy Changes News

Neurizon Therapeutics has boosted the participant count in its HEALEY ALS Platform Trial Regimen I from 160 to 240, capitalising on faster enrolment and philanthropic support to maintain costs and accelerate topline results to early Q3 2027.

Minbos Resources has secured a crucial milestone by signing the final security agreement for its US$16 million IDC loan and submitting a first drawdown request of US$4.8 million to fund ongoing construction at Cabinda.

Lithium Universe (ASX: LU7) has acquired exclusive global rights to a University of Edinburgh hydrometallurgical process that extracts gold and copper from electronic waste using recyclable organic compounds, positioning the company at the forefront of sustainable precious metals recovery.

Knosys has locked in a two-year, $3.8 million contract extension with ANZ, with full payment received upfront. This deal underpins Knosys’s role in ANZ’s AI integration efforts and strengthens the company’s cash position.

HighCom Limited has locked in a $4.5 million loan facility with Commonwealth Bank, replacing its US debt and complementing a recent $7.8 million capital raise to fuel working capital and sales expansion.

Phoslock Environmental Technologies reported a sales recovery in 2025 with further growth expected, backed by resumed production in China and promising European projects, while ongoing litigation clouds the outlook.

Critica Limited’s Jupiter Rare Earth Project pilot plant has delivered a significant beneficiation breakthrough, upgrading feed to a ~3% TREO intermediate concentrate with strong magnet rare earth recoveries and substantial mass rejection.

BWP Group has successfully closed its $228 million fully underwritten entitlement offer, with retail investors contributing $19 million and institutional investors covering the balance.

Trajan Group Holdings reports steady market demand and successful cost initiatives in H2 FY26 but warns of a $4 million revenue hit from Australian dollar appreciation.

Cryosite Limited delivered a robust 22% revenue increase and 28% EBITDA growth for the ten months to April 2026, powered by expanding clinical trial activity and infrastructure upgrades.

Barton Gold reports standout high-grade assays from Phase 2 drilling at Tunkillia’s Area 51, highlighting potential resource growth and open pit extensions that could extend mine life and underpin a Pre-Feasibility Study by year-end.

Prodigy Gold’s scoping study for the Hyperion Gold Deposit confirms a viable open pit project with a 4-year mine life and strong financial metrics, underpinned by a 454,000-ounce resource.